Question 1

What are the potential benefits of combining lenalidomide with R-CHOP for my specific situation?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Revlimid Dose 25 mg in Association With (R-CHOP) in the Treatment Follicular Lymphoma clinical trial (NCT01393756). Contact the study team or your healthcare provider for specific answers.

Question 2

How will this treatment affect my current health and any other medications I am taking?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Revlimid Dose 25 mg in Association With (R-CHOP) in the Treatment Follicular Lymphoma clinical trial (NCT01393756). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from this combination treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Revlimid Dose 25 mg in Association With (R-CHOP) in the Treatment Follicular Lymphoma clinical trial (NCT01393756). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for treatments and check-ups?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Revlimid Dose 25 mg in Association With (R-CHOP) in the Treatment Follicular Lymphoma clinical trial (NCT01393756). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects or my condition doesn't improve?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Revlimid Dose 25 mg in Association With (R-CHOP) in the Treatment Follicular Lymphoma clinical trial (NCT01393756). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any specific eligibility criteria I should be aware of before considering this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Revlimid Dose 25 mg in Association With (R-CHOP) in the Treatment Follicular Lymphoma clinical trial (NCT01393756). Contact the study team or your healthcare provider for specific answers.

What this study is about